Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Bioconjug Che
Manufacturers have substantially expanded production capacity and supply has gradually improved for most products through 2024 into 2025
On 24 November 2025, Novo Nordisk reported that oral semaglutide had failed to slow Alzheimers disease in the EVOKE and EVOKE+ trials, which together enrolled 3,808 participants and stand as the largest evaluation of this drug class in any neurodegenerative condition [1]
Stereoselective formation of glutathione S-conjugates from halovinylmercapturate [PMID: 10375004] Laboratory literature summary: Stereoselective formation of glutathione S-conjugates from halovinylmercapturate sulphoxides
US$ 23.85
US$ 28.91
US$ 23.73
US$ 23.86
US$ 26.83
US$ 24.20
